CAS: 298197-04-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Fatostatin A Hydrobromide REF: IN-DA00C31CCAS: 298197-04-3 | 98% | To inquire | Fri 14 Feb 25 | |
2-(2-Propylpyridin-4-Yl)-4-(P-Tolyl)Thiazole Hydrobromide REF: 54-OR1009705CAS: 298197-04-3 | 98% | 218.00 €~918.00 € | Tue 18 Feb 25 | |
Fatostatin hydrobromide REF: TM-T6832CAS: 298197-04-3 | 98.04% - 99.91% | 51.00 €~773.00 € | Fri 21 Feb 25 | |
Fatostatin REF: 3D-YLA19704CAS: 298197-04-3 | Min. 95% | - - - | Discontinued product |
Fatostatin A Hydrobromide
CAS:298197-04-3
Formula:
C18H19BrN2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
375.3259
Ref: IN-DA00C31C
1g | To inquire | ||
5mg | 61.00 € | ||
10mg | 99.00 € | ||
25mg | 161.00 € | ||
50mg | 194.00 € | ||
100mg | 305.00 € | ||
250mg | 487.00 € |
Estimated delivery in United States, on Friday 14 Feb 2025
2-(2-Propylpyridin-4-Yl)-4-(P-Tolyl)Thiazole Hydrobromide
CAS:298197-04-3
Purity:
98%
Molecular weight:
375.33g/mol
Ref: 54-OR1009705
1g | 918.00 € | ||
100mg | 218.00 € | ||
250mg | 352.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Fatostatin hydrobromide
CAS:298197-04-3
Fatostatin hydrobromide (Fatostatin A HBr), an inhibitor of sterol regulatory element binding protein (SREBP), impairs …
Formula:
C18H18N2S·HBr
Purity:
98.04% - 99.91%
Color and Shape:
Solid
Molecular weight:
375.33
Ref: TM-T6832
5mg | 51.00 € | ||
10mg | 73.00 € | ||
25mg | 117.00 € | ||
50mg | 188.00 € | ||
100mg | 320.00 € | ||
200mg | 462.00 € | ||
500mg | 773.00 € |
Estimated delivery in United States, on Friday 21 Feb 2025
Fatostatin
CAS:298197-04-3
Fatostatin is a benzylic diacid compound that has been extensively studied for its potential therapeutic …
Formula:
C18H18N2S·xHBr
Purity:
Min. 95%
Molecular weight:
375.33 g/mol
Ref: 3D-YLA19704
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |